Selective Wealth Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Selective Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$548.35 - $738.84 $27,417 - $36,942	-50 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$595.12 - $698.43 $148,780 - $174,607	-250 Reduced 83.33%	50 $35,000
Q4 2021 Jan 18, 2022	BUY	$543.48 - $670.97 $27,174 - $33,548	50 Added 20.0%	300 $189,000
Q3 2021 Oct 27, 2021	BUY	$574.03 - $680.96 $143,507 - $170,240	250 New	250 $151,000

1,531

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Selective Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Selective Wealth Management, Inc. with notifications on news.